Abstract
The human body follows 24 hours cycles called the circadian rhythm that affect many physiological and physiopathological processes. Chronotherapeutic diseases include asthma, cardiovascular diseases, cancer, rheumatoid arthritis and other algesia processes. Drugs behaviours in the human body are also strongly affected by circadian changes, especially in what concerns absorption and elimination. Anti-inflammatory drugs are excellent candidates to chronotherapeutical delivery. Chronotherapeutic products are able to synchronize drug delivery with circadian rhythms in order to enhance efficacy and reduce side effects. These products mainly offer pulsatile release that follow a sigmoid release profile with a combination of periods of lag time and periods of fast drug release. Many technologies, either single units or multiparticulate systems, have been suggested and some have been successfully marketed improving patients adherence and quality of life. This review aims to describe the circadian rhythms and their influences in therapeutics as well as the technologies that have been proposed to develop chronopharmaceutical dosage forms.
Keywords: Circadian rhythm, chronotherapy, chronopharmaceutics, pulsatile drug delivery, Chronopharmacodynamics, Chronotherapeutics, Chronotoxicology, Duodenal Ulcer, Osmotic Controlled Devices, Reservoir Devices
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Title: Chronopharmaceutical Delivery of Anti-Inflammatory Drugs
Volume: 10 Issue: 3
Author(s): Baratta P. and Lopes C.M.
Affiliation:
Keywords: Circadian rhythm, chronotherapy, chronopharmaceutics, pulsatile drug delivery, Chronopharmacodynamics, Chronotherapeutics, Chronotoxicology, Duodenal Ulcer, Osmotic Controlled Devices, Reservoir Devices
Abstract: The human body follows 24 hours cycles called the circadian rhythm that affect many physiological and physiopathological processes. Chronotherapeutic diseases include asthma, cardiovascular diseases, cancer, rheumatoid arthritis and other algesia processes. Drugs behaviours in the human body are also strongly affected by circadian changes, especially in what concerns absorption and elimination. Anti-inflammatory drugs are excellent candidates to chronotherapeutical delivery. Chronotherapeutic products are able to synchronize drug delivery with circadian rhythms in order to enhance efficacy and reduce side effects. These products mainly offer pulsatile release that follow a sigmoid release profile with a combination of periods of lag time and periods of fast drug release. Many technologies, either single units or multiparticulate systems, have been suggested and some have been successfully marketed improving patients adherence and quality of life. This review aims to describe the circadian rhythms and their influences in therapeutics as well as the technologies that have been proposed to develop chronopharmaceutical dosage forms.
Export Options
About this article
Cite this article as:
P. Baratta and C.M. Lopes, Chronopharmaceutical Delivery of Anti-Inflammatory Drugs, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry 2011; 10 (3) . https://dx.doi.org/10.2174/1871523011109030180
DOI https://dx.doi.org/10.2174/1871523011109030180 |
Print ISSN 1871-5230 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-614X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
NMR Based Metabolomics: An Exquisite and Facile Method for Evaluating Therapeutic Efficacy and Screening Drug Toxicity
Current Topics in Medicinal Chemistry Accelerating Drug Discovery by Integrative Implementation of Laboratory Automation in the Work Flow
Current Medicinal Chemistry Chemical Inhibition of Matrix Metalloproteinases for Periodontal Treatment
Clinical Anti-Inflammatory & Anti-Allergy Drugs (Discontinued) Development and Chemistry of Histamine H4 Receptor Ligands as Potential Modulators of Inflammatory and Allergic Responses
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Therapeutic Targeting of TRP Channels - The TR(i)P to Pain Relief
Current Topics in Medicinal Chemistry Anti-inflammatory Potential of GSK-3 Inhibitors
Current Drug Targets Potential Crossreactivity of Human Immune Responses Against HCMV Glycoprotein B
Current Drug Discovery Technologies Halting Arterial Aging in Patients with Cardiovascular Disease: Hypolipidemic and Antihypertensive Therapy
Current Pharmaceutical Design Exploring Interaction of TNF and Orthopoxviral CrmB Protein by Surface Plasmon Resonance and Free Energy Calculation
Protein & Peptide Letters The Role of Signaling Pathway in the Biological Cause of Rheumatoid Arthritis
Current Drug Research Reviews New Approaches to Antidepressant Drug Design: Cytokine-Regulated Pathways
Current Pharmaceutical Design NLRP3 Inflammasome Activation Leading to IL-1 – IL-17 Dependent Lung Inflammation and Fibrosis
Current Respiratory Medicine Reviews Comparative Molecular Characterization to Reveal Surface Behaviour of Non-proteolytic Bromelain Mutants
Current Pharmaceutical Biotechnology A Quantitative Structure-Activity Relationship Study on Some Novel Series of Hydroxamic Acid Analogs Acting as Matrix Metalloproteinase Inhibitors
Medicinal Chemistry Vitamin D, Sunlight and Cancer Connection
Anti-Cancer Agents in Medicinal Chemistry Cellular and Molecular Regulation of Inflammatory Pain, Nociception and Hyperalgesia - The Role of the Transcription Factor NF-κB as the Lynchpin Nocisensor: Hyperalgesic or Analgesic Effect?
Current Immunology Reviews (Discontinued) Role of AGEs-RAGE System in Cardiovascular Disease
Current Pharmaceutical Design Effects of Physical Exercise on Depressive Symptoms and Biomarkers in Depression
CNS & Neurological Disorders - Drug Targets Role of Synovial Fibroblasts in Rheumatoid Arthritis
Current Pharmaceutical Design The Role of Cannabinoids in Inflammatory Modulation of Allergic Respiratory Disorders, Inflammatory Pain and Ischemic Stroke
Current Drug Targets